Elexacaftor/tezacaftor/ivacaftor improves chronic rhinosinusitis detected by magnetic resonance imaging in children with cystic fibrosis on long-term therapy with lumacaftor/ivacaftor

Introduction: Previous studies using magnetic resonance imaging (MRI) demonstrated early onset and progression of chronic rhinosinusitis (CRS) from infancy to school age, and response to lumacaftor/ivacaftor (LUM/IVA) therapy in children with cystic fibrosis (CF). However, the effect of elexacaftor/...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Wucherpfennig, Lena (VerfasserIn) , Becker, Johanna K. Z. (VerfasserIn) , Wuennemann, Felix (VerfasserIn) , Eichinger, Monika (VerfasserIn) , Seitz, Angelika (VerfasserIn) , Baumann, Ingo (VerfasserIn) , Stahl, Mirjam (VerfasserIn) , Graeber, Simon Y. (VerfasserIn) , Zhao, Shengkai (VerfasserIn) , Chung, Jaehi (VerfasserIn) , Schenk, Jens-Peter (VerfasserIn) , Alrajab, Abdulsattar (VerfasserIn) , Kauczor, Hans-Ulrich (VerfasserIn) , Mall, Marcus A. (VerfasserIn) , Sommerburg, Olaf (VerfasserIn) , Wielpütz, Mark Oliver (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: March 2024
In: Journal of cystic fibrosis
Year: 2024, Jahrgang: 23, Heft: 2, Pages: 234-241
ISSN:1873-5010
DOI:10.1016/j.jcf.2024.01.004
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1016/j.jcf.2024.01.004
Verlag, kostenfrei, Volltext: https://www.sciencedirect.com/science/article/pii/S1569199324000043
Volltext
Verfasserangaben:Lena Wucherpfennig, Johanna K. Z. Becker, Felix Wuennemann, Monika Eichinger, Angelika Seitz, Ingo Baumann, Mirjam Stahl, Simon Y. Graeber, Shengkai Zhao, Jaehi Chung, Jens-Peter Schenk, Abdulsattar Alrajab, Hans-Ulrich Kauczor, Marcus A. Mall, Olaf Sommerburg, Mark O. Wielpütz

MARC

LEADER 00000caa a2200000 c 4500
001 1931570973
003 DE-627
005 20250913141738.0
007 cr uuu---uuuuu
008 250723s2024 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.jcf.2024.01.004  |2 doi 
035 |a (DE-627)1931570973 
035 |a (DE-599)KXP1931570973 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Wucherpfennig, Lena  |d 1992-  |e VerfasserIn  |0 (DE-588)1200972732  |0 (DE-627)1684107172  |4 aut 
245 1 0 |a Elexacaftor/tezacaftor/ivacaftor improves chronic rhinosinusitis detected by magnetic resonance imaging in children with cystic fibrosis on long-term therapy with lumacaftor/ivacaftor  |c Lena Wucherpfennig, Johanna K. Z. Becker, Felix Wuennemann, Monika Eichinger, Angelika Seitz, Ingo Baumann, Mirjam Stahl, Simon Y. Graeber, Shengkai Zhao, Jaehi Chung, Jens-Peter Schenk, Abdulsattar Alrajab, Hans-Ulrich Kauczor, Marcus A. Mall, Olaf Sommerburg, Mark O. Wielpütz 
264 1 |c March 2024 
300 |b Illustrationen 
300 |a 8 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Online verfügbar: 13. Januar 2024, Artikelversion: 17. Mai 2024 
500 |a Gesehen am 23.07.2025 
520 |a Introduction: Previous studies using magnetic resonance imaging (MRI) demonstrated early onset and progression of chronic rhinosinusitis (CRS) from infancy to school age, and response to lumacaftor/ivacaftor (LUM/IVA) therapy in children with cystic fibrosis (CF). However, the effect of elexacaftor/tezacaftor/ivacaftor (ELX/TEZ/IVA) on CRS detected by MRI in children with CF and at least one F508del mutation, and potential incremental effects of ELX/TEZ/IVA compared to LUM/IVA in F508del homozygous children have not been studied. Methods: 30 children with CF with at least one F508del mutation underwent three longitudinal paranasal sinus MRI before (MRI1), without (n = 16) or with LUM/IVA therapy (n = 14, MRI2), and with ELX/TEZ/IVA therapy (MRI3, mean age at therapy initiation 11.1 ± 3.4y, range 6-16y). MRI were evaluated using the CRS-MRI score. Results: After therapy initiation with ELX/TEZ/IVA, the prevalence and in maxillary and sphenoid sinuses the dominance of mucopyoceles decreased (35% vs. 0 %, p<0.001 and 26% vs. 8 %, p < 0.05, respectively). This leads to a reduction in mucopyocele subscore (-3.4 ± 1.9, p < 0.001), and sinus subscores in MRI3 (maxillary sinus: -5.3 ± 3.1, p < 0.001, frontal sinus: -1.0 ± 1.9, p < 0.01, sphenoid subscore: -2.8 ± 3.5, p < 0.001, ethmoid sinus: -1.7 ± 1.9, p < 0.001). The CRS-MRI sum score decreased after therapy initiation with ELX/TEZ/IVA by -9.6 ± 5.5 score points (p < 0.001). The strength in reduction of mucopyoceles subscore and CRS-MRI sum score was independent of a pretreatment with LUM/IVA from MRI1-MRI2 (p = 0.275-0.999). Conclusions: ELX/TEZ/IVA therapy leads to improvement of CRS in eligible children with CF. Our data support the role of MRI for comprehensive monitoring of CRS disease severity and response to therapy in children with CF. 
650 4 |a Airway disease 
650 4 |a Chronic rhinosinusitis 
650 4 |a Cystic fibrosis 
650 4 |a Magnetic resonance imaging 
650 4 |a Mucus obstruction 
700 1 |a Becker, Johanna K. Z.  |e VerfasserIn  |4 aut 
700 1 |a Wuennemann, Felix  |e VerfasserIn  |4 aut 
700 1 |a Eichinger, Monika  |d 1964-  |e VerfasserIn  |0 (DE-588)1049617525  |0 (DE-627)78269117X  |0 (DE-576)172609712  |4 aut 
700 1 |a Seitz, Angelika  |e VerfasserIn  |0 (DE-588)1106414179  |0 (DE-627)863139701  |0 (DE-576)474107019  |4 aut 
700 1 |a Baumann, Ingo  |d 1977-  |e VerfasserIn  |0 (DE-588)13336982X  |0 (DE-627)544029445  |0 (DE-576)275438732  |4 aut 
700 1 |a Stahl, Mirjam  |e VerfasserIn  |0 (DE-588)1050007778  |0 (DE-627)783125836  |0 (DE-576)404265367  |4 aut 
700 1 |a Graeber, Simon Y.  |e VerfasserIn  |4 aut 
700 1 |a Zhao, Shengkai  |d 1994-  |e VerfasserIn  |0 (DE-588)1292248319  |0 (DE-627)1847657893  |4 aut 
700 1 |a Chung, Jaehi  |e VerfasserIn  |0 (DE-588)1252303602  |0 (DE-627)1793448914  |4 aut 
700 1 |a Schenk, Jens-Peter  |e VerfasserIn  |0 (DE-588)1055855114  |0 (DE-627)792738667  |0 (DE-576)260795577  |4 aut 
700 1 |a Alrajab, Abdulsattar  |d 1972-  |e VerfasserIn  |0 (DE-588)1032546344  |0 (DE-627)738536725  |0 (DE-576)380101068  |4 aut 
700 1 |a Kauczor, Hans-Ulrich  |d 1962-  |e VerfasserIn  |0 (DE-588)139267123  |0 (DE-627)70327113X  |0 (DE-576)310955327  |4 aut 
700 1 |a Mall, Marcus A.  |e VerfasserIn  |4 aut 
700 1 |a Sommerburg, Olaf  |d 1967-  |e VerfasserIn  |0 (DE-588)172907470  |0 (DE-627)69783543X  |0 (DE-576)133762270  |4 aut 
700 1 |a Wielpütz, Mark Oliver  |d 1982-  |e VerfasserIn  |0 (DE-588)139999752  |0 (DE-627)614754682  |0 (DE-576)314127046  |4 aut 
773 0 8 |i Enthalten in  |t Journal of cystic fibrosis  |d Amsterdam [u.a.] : Elsevier Science, 2002  |g 23(2024), 2 vom: März, Seite 234-241  |h Online-Ressource  |w (DE-627)35598539X  |w (DE-600)2091075-7  |w (DE-576)271360909  |x 1873-5010  |7 nnas  |a Elexacaftor/tezacaftor/ivacaftor improves chronic rhinosinusitis detected by magnetic resonance imaging in children with cystic fibrosis on long-term therapy with lumacaftor/ivacaftor 
773 1 8 |g volume:23  |g year:2024  |g number:2  |g month:03  |g pages:234-241  |g extent:8  |a Elexacaftor/tezacaftor/ivacaftor improves chronic rhinosinusitis detected by magnetic resonance imaging in children with cystic fibrosis on long-term therapy with lumacaftor/ivacaftor 
856 4 0 |u https://doi.org/10.1016/j.jcf.2024.01.004  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://www.sciencedirect.com/science/article/pii/S1569199324000043  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20250723 
993 |a Article 
994 |a 2024 
998 |g 139999752  |a Wielpütz, Mark Oliver  |m 139999752:Wielpütz, Mark Oliver  |d 910000  |d 911400  |d 50000  |e 910000PW139999752  |e 911400PW139999752  |e 50000PW139999752  |k 0/910000/  |k 1/910000/911400/  |k 0/50000/  |p 16  |y j 
998 |g 172907470  |a Sommerburg, Olaf  |m 172907470:Sommerburg, Olaf  |d 910000  |d 910500  |d 50000  |e 910000PS172907470  |e 910500PS172907470  |e 50000PS172907470  |k 0/910000/  |k 1/910000/910500/  |k 0/50000/  |p 15 
998 |g 139267123  |a Kauczor, Hans-Ulrich  |m 139267123:Kauczor, Hans-Ulrich  |d 910000  |d 911400  |e 910000PK139267123  |e 911400PK139267123  |k 0/910000/  |k 1/910000/911400/  |p 13 
998 |g 1032546344  |a Alrajab, Abdulsattar  |m 1032546344:Alrajab, Abdulsattar  |d 910000  |d 911400  |e 910000PA1032546344  |e 911400PA1032546344  |k 0/910000/  |k 1/910000/911400/  |p 12 
998 |g 1055855114  |a Schenk, Jens-Peter  |m 1055855114:Schenk, Jens-Peter  |d 910000  |d 911400  |d 50000  |e 910000PS1055855114  |e 911400PS1055855114  |e 50000PS1055855114  |k 0/910000/  |k 1/910000/911400/  |k 0/50000/  |p 11 
998 |g 1252303602  |a Chung, Jaehi  |m 1252303602:Chung, Jaehi  |d 910000  |d 910500  |e 910000PC1252303602  |e 910500PC1252303602  |k 0/910000/  |k 1/910000/910500/  |p 10 
998 |g 1292248319  |a Zhao, Shengkai  |m 1292248319:Zhao, Shengkai  |d 910000  |d 911400  |e 910000PZ1292248319  |e 911400PZ1292248319  |k 0/910000/  |k 1/910000/911400/  |p 9 
998 |g 1050007778  |a Stahl, Mirjam  |m 1050007778:Stahl, Mirjam  |d 50000  |e 50000PS1050007778  |k 0/50000/  |p 7 
998 |g 13336982X  |a Baumann, Ingo  |m 13336982X:Baumann, Ingo  |d 910000  |d 911100  |d 50000  |e 910000PB13336982X  |e 911100PB13336982X  |e 50000PB13336982X  |k 0/910000/  |k 1/910000/911100/  |k 0/50000/  |p 6 
998 |g 1106414179  |a Seitz, Angelika  |m 1106414179:Seitz, Angelika  |d 910000  |d 911100  |e 910000PS1106414179  |e 911100PS1106414179  |k 0/910000/  |k 1/910000/911100/  |p 5 
998 |g 1049617525  |a Eichinger, Monika  |m 1049617525:Eichinger, Monika  |d 50000  |e 50000PE1049617525  |k 0/50000/  |p 4 
998 |g 1200972732  |a Wucherpfennig, Lena  |m 1200972732:Wucherpfennig, Lena  |d 910000  |d 911400  |e 910000PW1200972732  |e 911400PW1200972732  |k 0/910000/  |k 1/910000/911400/  |p 1  |x j 
999 |a KXP-PPN1931570973  |e 4749045918 
BIB |a Y 
SER |a journal 
JSO |a {"id":{"doi":["10.1016/j.jcf.2024.01.004"],"eki":["1931570973"]},"name":{"displayForm":["Lena Wucherpfennig, Johanna K. Z. Becker, Felix Wuennemann, Monika Eichinger, Angelika Seitz, Ingo Baumann, Mirjam Stahl, Simon Y. Graeber, Shengkai Zhao, Jaehi Chung, Jens-Peter Schenk, Abdulsattar Alrajab, Hans-Ulrich Kauczor, Marcus A. Mall, Olaf Sommerburg, Mark O. Wielpütz"]},"title":[{"title":"Elexacaftor/tezacaftor/ivacaftor improves chronic rhinosinusitis detected by magnetic resonance imaging in children with cystic fibrosis on long-term therapy with lumacaftor/ivacaftor","title_sort":"Elexacaftor/tezacaftor/ivacaftor improves chronic rhinosinusitis detected by magnetic resonance imaging in children with cystic fibrosis on long-term therapy with lumacaftor/ivacaftor"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"language":["eng"],"note":["Online verfügbar: 13. Januar 2024, Artikelversion: 17. Mai 2024","Gesehen am 23.07.2025"],"origin":[{"dateIssuedDisp":"March 2024","dateIssuedKey":"2024"}],"person":[{"display":"Wucherpfennig, Lena","family":"Wucherpfennig","role":"aut","given":"Lena"},{"display":"Becker, Johanna K. Z.","role":"aut","given":"Johanna K. Z.","family":"Becker"},{"given":"Felix","role":"aut","family":"Wuennemann","display":"Wuennemann, Felix"},{"family":"Eichinger","role":"aut","given":"Monika","display":"Eichinger, Monika"},{"display":"Seitz, Angelika","given":"Angelika","role":"aut","family":"Seitz"},{"given":"Ingo","role":"aut","family":"Baumann","display":"Baumann, Ingo"},{"given":"Mirjam","role":"aut","family":"Stahl","display":"Stahl, Mirjam"},{"role":"aut","given":"Simon Y.","family":"Graeber","display":"Graeber, Simon Y."},{"family":"Zhao","role":"aut","given":"Shengkai","display":"Zhao, Shengkai"},{"display":"Chung, Jaehi","given":"Jaehi","role":"aut","family":"Chung"},{"role":"aut","given":"Jens-Peter","family":"Schenk","display":"Schenk, Jens-Peter"},{"display":"Alrajab, Abdulsattar","family":"Alrajab","role":"aut","given":"Abdulsattar"},{"display":"Kauczor, Hans-Ulrich","family":"Kauczor","given":"Hans-Ulrich","role":"aut"},{"display":"Mall, Marcus A.","role":"aut","given":"Marcus A.","family":"Mall"},{"display":"Sommerburg, Olaf","given":"Olaf","role":"aut","family":"Sommerburg"},{"display":"Wielpütz, Mark Oliver","family":"Wielpütz","role":"aut","given":"Mark Oliver"}],"relHost":[{"disp":"Elexacaftor/tezacaftor/ivacaftor improves chronic rhinosinusitis detected by magnetic resonance imaging in children with cystic fibrosis on long-term therapy with lumacaftor/ivacaftorJournal of cystic fibrosis","physDesc":[{"extent":"Online-Ressource"}],"recId":"35598539X","note":["Gesehen am 10.02.2016"],"type":{"media":"Online-Ressource","bibl":"periodical"},"language":["eng"],"title":[{"subtitle":"the official journal of the European Cystic Fibrosis Society","title_sort":"Journal of cystic fibrosis","title":"Journal of cystic fibrosis"}],"origin":[{"dateIssuedKey":"2002","publisherPlace":"Amsterdam [u.a.]","dateIssuedDisp":"2002-","publisher":"Elsevier Science"}],"part":{"volume":"23","year":"2024","extent":"8","text":"23(2024), 2 vom: März, Seite 234-241","issue":"2","pages":"234-241"},"id":{"zdb":["2091075-7"],"issn":["1873-5010"],"eki":["35598539X"]},"pubHistory":["1.2002 -"],"titleAlt":[{"title":"Cystic fibrosis"}]}],"recId":"1931570973","physDesc":[{"extent":"8 S.","noteIll":"Illustrationen"}]} 
SRT |a WUCHERPFENELEXACAFTO2024